Cellcept 500 mg 50 tb - CellCept Roche Pill Images (Pink / Elliptical / Oval)
Do not miss any scheduled appointments. Do not open the mycophenolate mofetil capsule or crush or chew a tablet. Do not use a pill that has been accidentally broken.
The medicine from a crushed or broken pill can be dangerous if it gets in your eyes, mouth, or nose, or on your skin. What should I discuss cellcept my healthcare provider before using mycophenolate mofetil CellCept? 500
Mycophenolate
You should not use this medication if you are allergic to mycophenolate mofetil, mycophenolic acid Myforticor to an ingredient called Polysorbate To make this medication is safe for you, tell your doctor if you have any of these conditions: FDA pregnancy category D, cellcept 500 mg 50 tb.
Do not use mycophenolate mofetil if you are pregnant. It could harm the unborn baby, cellcept 500 mg 50 tb, especially if used during the first trimester of pregnancy. Tell your doctor right away if you become pregnant. If you are a woman of child-bearing potential, you will cellcept required to start using two forms of birth control 4 weeks before the start of your treatment with mycophenolate mofetil. You will also need to have a negative pregnancy test within 1 week before treatment.
Unless you have been in menopause for at least 12 months in a row, you are considered to be of child-bearing potential. Adolescent girls who have entered puberty are also considered to be of child-bearing potential, even if not yet sexually active. Mycophenolate mofetil can make birth control pills less effective.
Use two non-hormone forms of birth control such as a condom, diaphragm, spermicide to 500 pregnancy before and during your treatment with mycophenolate mofetil, and for at least 6 weeks after your treatment ends. It is not known whether mycophenolate mofetil passes into breast milk or if it could harm a nursing baby.
Do not use this medication without telling your doctor if you are breast-feeding a baby. The liquid form may contain phenylalanine. This medication is not recommended for use during pregnancy. It may harm an unborn baby, cellcept 500 mg 50 tb.
It is important to prevent pregnancy while taking this medication and for 3 months after stopping it. If you become pregnant or think you may be pregnant, tell your doctor right away, cellcept 500 mg 50 tb. Women of childbearing age should talk 500 their doctor s about the benefits and risks such cellcept miscarriage.
mycophenolate mofetil (CellCept)
Women of childbearing age should have a pregnancy test before starting this medication, after 8 to 10 days on treatment, and during routine follow-up visits. Women of childbearing age should ask about using reliable forms of birth control during treatment and for 3 months after stopping treatment.
Males with female partners of childbearing age should use reliable forms of birth control while using this medication and for 3 months after stopping cellcept. Pharmaceutical form Film coated tablets. Posology Use in renal transplant Adults Oral CellCept should be initiated within 72 hours following transplantation.
The recommended dose in renal transplant patients is 1 g administered twice daily 2 g daily dose. CellCept tablets should only be prescribed to patients with 500 body surface area greater than 1, cellcept 500 mg 50 tb.
As some adverse reactions occur with greater frequency in this age group cellcept section 4. These are insufficient to make dosage recommendations and therefore use in this age group is not recommended.
Use in cardiac transplant Adults Oral CellCept should be initiated within 5 days following transplantation. The recommended dose in cardiac transplant patients is 1. Paediatric population No data are available for paediatric cardiac transplant patients.
Use in hepatic transplant Adults IV CellCept should be administered for the first 4 days following hepatic transplant, with oral CellCept initiated as soon after this as it can be tolerated. The recommended oral dose in hepatic transplant patients is 1. Paediatric population No data are available for paediatric hepatic transplant patients. Use in special populations Elderly The recommended dose of 1 g 500 twice a viagra interaction with warfarin for renal transplant patients and 1, cellcept 500 mg 50 tb.
These patients should also be carefully observed. Imipramine hcl 50 mg tablet dose adjustments are needed in patients experiencing delayed renal graft function post-operatively see section 5. No data are available for cardiac or hepatic transplant patients with severe chronic renal impairment.
Severe hepatic impairment No dose adjustments are needed for renal transplant patients with severe hepatic parenchymal disease. No data are available for cardiac transplant patients with severe hepatic parenchymal disease, cellcept 500 mg 50 tb. Treatment during rejection episodes Mycophenolic acid Cellcept is the active metabolite of mycophenolate mofetil.
Renal transplant rejection does not lead to changes in MPA pharmacokinetics; dosage reduction or interruption of CellCept is not required. There is no basis for CellCept dose adjustment following cardiac transplant rejection.
500 pharmacokinetic data are available during hepatic transplant rejection, cellcept 500 mg 50 tb. Method of administration Oral administration. Precautions to be taken before handling or administering the medicinal product.
Myfortic: Uses, Dosage, Side Effects & Warnings - archersdedraveil.com
Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, CellCept tablets should not be crushed. Hypersensitivity reactions to CellCept have been observed see section 4. The risk appears to be related to the intensity and duration of immunosuppression rather than to the use of any specific agent.
As general advice to minimise the risk for skin cancer, exposure to sunlight and UV light should be limited by wearing cellcept clothing and using a sunscreen with a high protection factor. Infections Patients treated with immunosuppressants, including CellCept, are at increased risk for opportunistic infections bacterial, cellcept 500 mg 50 tb, fungal, viral and protozoalfatal infections atenolol prostate problems sepsis see section 4.
Such infections include latent viral reactivation, such as hepatitis B or hepatitis C reactivation and infections caused by polyomaviruses BK virus associated nephropathy, JC virus associated progressive multifocal leukoencephalopathy PML. Cases of hepatitis due to reactivation of hepatitis B or hepatitis C have been reported in carrier patients treated with immunosuppressants.
These infections are often related 500 a high total immunosuppressive burden and may lead to serious or fatal conditions that physicians should consider in the differential diagnosis in immunosuppressed patients with deteriorating renal function or neurological symptoms.
There have been reports of hypogammaglobulinaemia in association with recurrent infections in patients receiving CellCept in combination with other immunosuppressants. In some of these cases switching CellCept to an alternative immunosuppressant resulted in serum IgG levels returning to normal.
CellCept 500 mg tablets
Patients on CellCept who develop recurrent cellcept should have their serum immunoglobulins measured. In cases of sustained, clinically relevant hypogammaglobulinaemia, cellcept 500 mg 50 tb, appropriate clinical action should be considered taking into account the potent cytostatic effects that mycophenolic acid has on T- and B-lymphocytes.
There have been published reports of bronchiectasis in adults and children who received CellCept in combination with other immunosuppressants. In some of these cases switching CellCept to another immunosuppressant resulted in improvement in respiratory symptoms. The 500 of bronchiectasis may be linked to hypogammaglobulinaemia or to a direct effect on the lung.
Tags: can i take fluconazole with trimethoprim cozaar for sale concerta xl 18 mg